Tel-Aviv and Haifa, Israel March 2017

The diagnostics company Emosis Ltd., BioRap Technologies and Rambam MedTech Ltd, the technology transfer companies of the Rappaport Institute at the Technion - Israel Institute of Technology and Rambam Healthcare Campus, have entered into an exclusive license agreement to develop and commercialize hypercoagulation kit for several indications based on microparticles.